Constitutive NF-kB activation in CRC tissue correlates with tumor progression and may influence both colitis-associated and sporadic CRC (sCRC) through its connections to angiogenesis and chemotherapy resistance. The gene discussed is NFKB1; the disease is colorectal carcinoma.